A passion for science

Advanced Biomimetic Sensors (ABS), Inc. is a pioneer in the development and commercialization of innovative reagentless diagnostic medical devices. These devices can be both hand-held and implantable for continuing monitoring. ABS intends to develop prototype devices to provide the market with a new generation of more accurate, sensitive, less expensive and pain-free medical devices, such as glucose monitoring for diabetics, especially suitable for diabetic children.

About the Founder

ABS was founded in 2006 by Dr. Ellen Chen. She brings deep passion to her research - a passion born out of compassion. She founded her company with the intent to use technology to reduce the suffering endured by patients, and by children in particular.

Dr. Chen was a Principal Investigator at the Center for Devices and Radiological Health (CDRH) at the U.S. Food and Drug Administration (US FDA). During her tenure, she was a Project Manager responsible for conducting a multiple-center clinical study regarding the development of an industry standard for evaluation of the performance of self-monitoring blood glucose (SMBG) meters. Dr. Chen’s research team received the Special Recognition Award from the FDA in 2001. The Award states: For outstanding scientific expertise and leadership in addressing critical issues impacting the health of 16 million diabetics who use SMBG devices. The research team consisted of a team from the Clinical Center in NIH, a team from the Johns Hopkins Clinical Center and a team from the University of Maryland Clinical System.

Dr. Chen’s interests are in the areas of biosensor, fuel cell energy, nanotechnology, biomimetic membrane chemistry and clinical chemistry. Dr. Chen has more than 15 years experience in developing innovative biosensor systems and she held intelligent properties (IPs) in nano-biomimetic sensors; especially in nano-structured sensors for environmental and human health applications.

Management Team

Advisory Board and Consultants

Show-Hong Duh, Ph.D., Associate Director of Clinical Pathology at University of Maryland Health System, is the Advisory Board member for clinical pathology
Pete T. Kissinger, Chemistry Professor at Purdue University, Ph.D. President/CEO of Phlebotics, Inc.and Prosolia, Inc. is the Advisory Board Chairman in science
Susan Prince, Marketing Consultant
Elizabeth Smith, Ph.D. MBA, Business Development Consultant

Web Sites for Diabetes and Cancer Information

Juvenile Diabetes Research Foundation International
www.jdrf.org
National Institute of Diabetes and Digestive and Kinday Diseases
www.niddk.nih.gov;
www.nichd.nih.gov
American Diabetes Association
www.diabetes.org
Center for Diseases Control and Prevention
www.cdc.gov
The US Food and Drug Administration
www.fda.gov
www.cancer.gov
www.tnbcfoundation.org